JPRN-UMIN000009551
Completed
Phase 3
A Single Arm Clinical Trial in Japan for Reconstruction of Obstructive Lesions of the Superficial Femoral Artery or Proximal Popliteal Artery by Bard LifeStent - RELIABLE
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Symptomatic occlusive disease of the peripheral arteries
- Sponsor
- Medicon Inc.
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. The subject has concomitant renal failure with a creatinine of \>2\.5 mg/dl or having dialysis treatment. 2\. Subject has a history of bypass surgery on the study vessel. 3\. Subject has a history of MI or stroke within 6 months of study procedure.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A Phase II, Single-arm, Japanese Multicenter Trial of TH-302 in Combination with Doxorubicin in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma(EMR 200592-008)ocally advanced unresectable or metastatic STSJPRN-jRCT2080222619Merck Serono Co., Ltd.46
Completed
Not Applicable
Japan Prospective Long Term Clinical Trial in Type 2 Diabetes Patients with Sulfonyl Urea and SitagliptiType 2 diabetesJPRN-UMIN000005415Kyoto University Graduate School of Medicine250
Completed
Phase 1
Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersAcquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary BypassHealthyNCT01153997Novo Nordisk A/S24
Completed
Not Applicable
Japanease multi-center clinical trial to assess the inhibitory effects of branched chain amino acids on the recurrence after curative treatment of hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000002330Ministry of Health, Labour and Welfare200
Completed
Phase 4
Safety and Efficacy of Insulin Aspart in Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01649570Novo Nordisk A/S123